Cookies

Like most websites The Medicine Maker uses cookies. In order to deliver a personalized, responsive service and to improve the site, we remember and store information about how you use it. Learn more.
Subscribe to Newsletter

Search

Reset Filter
You have a filtered search result

155 search results for ‘*’


Business & Regulation COVID-19

From COVID-19 to Monkeypox

| Stephanie Sutton

It’s been a busy time for infectious disease vaccine news in Europe.


Business & Regulation Profession

The Best of Both Worlds

| Viktoria Gessner, Angelino Doppiu | 4 min read

Academia-industry collaboration doesn’t have to be difficult; we just need to appreciate one another’s differences.

Manufacture Packaging

Patient-Centric Packaging: the Metamorphosis

| Daria Dziura | 3 min read

Packaging should be about patients, but how can we turn a decades-old philosophy into the status quo?

Business & Regulation Marketing

Patients, Be Not Afraid

| Ben Beckley | 2 min read

How we can begin overcoming patients’ fears and misconceptions of cell and gene therapy

Business & Regulation Digital Technologies

Making the Most of Big Data

| Devesh Verma, Brian Gibbs | 4 min read

How AI can be leveraged to improve patient acquisition.

Business & Regulation Business Practice

Finding the True Meaning of Disruption

| Noel Maestre

Disruptive technologies are often talked about in pharma circles. But when it comes to AI, what long-term impact will it have?

Business & Regulation Business Practice

A Certain Shade of Green

| Andrew Toher | 5 min read

Pharmaceutical manufacturers burn through huge amounts of energy – so they need sustainable energy strategies.

Business & Regulation Trends & Forecasts

How COVID-19 Saved Pfizer’s Revenue

| Stephanie Sutton | 3 min read

Our animated chart illustrates Pfizer’s changing fortunes – and the significant contribution its COVID-19 efforts have made to revenues.

Business & Regulation Digital Technologies

Out With The Old

| Angelo Stracquatanio

To see true progress, pharma manufacturers will have to do away with their legacy systems.

Business & Regulation Business Practice

Pharma’s Green Progress and Pitfalls

| Michael Earl | 4 min read

Where are pharma companies falling behind when it comes to the environment?

Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine

Register